Possibility to use barycytinib in patients with COVID-19, including for treatment of «cytokine storm»
Until clinical trials of efficacy and safety are obtained, routine use of barycytinib in patients with COVID-19 cannot be recommended.
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Libro |
| Pubblicazione: |
Izdatelstvo OKI,
2020-10-01T00:00:00Z.
|
| Soggetti: | |
| Accesso online: | Connect to this object online. |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Accesso online
Connect to this object online.3rd Floor Main Library
| Collocazione: |
A1234.567 |
|---|---|
| Copia 1 | Disponibile |